Register

Pulmonology

Breast Cancer, Metastatic   

Questions discussed in this category

How do you monitor for pulmonary toxicity for patients on trastuzumab deruxtecan?
Would you obtain baseline PFT on all patients or only selected high risk patients? Would you repeat PFTs regularly or only if clinically symptomatic?&...
5 Answers available


Papers discussed in this category

Cancer Treat Rev, 2022 Mar 12
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management.

Related Topics in Pulmonology

Copyright © 2025 theMednet
All Rights Reserved.